Teva Pharmaceuticals International GmbH et al v. Fresenius Kabi USA, LLC > Summary
Court Case Number 1:17-cv-01201
Filing Date Aug 24, 2017
Termination Date Jul 6, 2020
Court Delaware District Court
Status Judgment - Court Trial
Appeal2020-2134
JudgesColm F. Connolly
Defendant
Plaintiff Attorneys
40TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Karen E. Keller
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Martha C. Kidd
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: John W. Shaw
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: David I. Berl
Williams & Connolly
Cephalon (Teva)
Attorney Name: Adam D. Harber
Williams & Connolly
Cephalon (Teva)
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Karen E. Keller
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Martha C. Kidd
Williams & Connolly
Cephalon (Teva)
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
Cephalon (Teva)
Attorney Name: John W. Shaw
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel G. Brown
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Michelle L. Ernst
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Karen E. Keller
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Kenneth G. Schuler
Latham & Watkins
Eagle Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Marc N. Zubick
Latham & Watkins
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Nathan R. Hoeschen
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Karen E. Keller
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Martha C. Kidd
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Shaun P. Mahaffy
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: John W. Shaw
Cephalon (Teva)
Attorney Name: David I. Berl
Cephalon (Teva)
Attorney Name: Adam D. Harber
Cephalon (Teva)
Attorney Name: Nathan R. Hoeschen
Cephalon (Teva)
Attorney Name: Karen E. Keller
Cephalon (Teva)
Attorney Name: Martha C. Kidd
Cephalon (Teva)
Attorney Name: Shaun P. Mahaffy
Cephalon (Teva)
Attorney Name: John W. Shaw
Eagle Pharmaceuticals, Inc.
Attorney Name: Daniel G. Brown
Eagle Pharmaceuticals, Inc.
Attorney Name: Michelle L. Ernst
Eagle Pharmaceuticals, Inc.
Attorney Name: Karen E. Keller
Eagle Pharmaceuticals, Inc.
Attorney Name: Kenneth G. Schuler
Eagle Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
Defendant Attorneys
8Fresenius Kabi USA
Attorney Name: Brian E. Farnan
Farnan LLP
Fresenius Kabi USA
Attorney Name: Helen H. Ji
ArentFox Schiff
Fresenius Kabi USA
Attorney Name: Arun J. Mohan
ArentFox Schiff
Fresenius Kabi USA
Attorney Name: Kevin M. Nelson
ArentFox Schiff
Fresenius Kabi USA
Attorney Name: Brian E. Farnan
Fresenius Kabi USA
Attorney Name: Helen H. Ji
Fresenius Kabi USA
Attorney Name: Arun J. Mohan
Fresenius Kabi USA
Attorney Name: Kevin M. Nelson
Counter Defendant
32Cephalon (Teva)
Attorney Name: David I. Berl
Williams & Connolly
Cephalon (Teva)
Attorney Name: Adam D. Harber
Williams & Connolly
Cephalon (Teva)
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Karen E. Keller
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: Martha C. Kidd
Williams & Connolly
Cephalon (Teva)
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
Cephalon (Teva)
Attorney Name: John W. Shaw
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: Karen E. Keller
Shaw Keller LLP
Eagle Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Karen E. Keller
Shaw Keller LLP
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Martha C. Kidd
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: John W. Shaw
Shaw Keller LLP
Cephalon (Teva)
Attorney Name: David I. Berl
Cephalon (Teva)
Attorney Name: Adam D. Harber
Cephalon (Teva)
Attorney Name: Nathan R. Hoeschen
Cephalon (Teva)
Attorney Name: Karen E. Keller
Cephalon (Teva)
Attorney Name: Martha C. Kidd
Cephalon (Teva)
Attorney Name: Shaun P. Mahaffy
Cephalon (Teva)
Attorney Name: John W. Shaw
Eagle Pharmaceuticals, Inc.
Attorney Name: Karen E. Keller
Eagle Pharmaceuticals, Inc.
Attorney Name: John W. Shaw
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: David I. Berl
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Adam D. Harber
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Nathan R. Hoeschen
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Karen E. Keller
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Martha C. Kidd
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Shaun P. Mahaffy
TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: John W. Shaw
Counter Claimant
4Fresenius Kabi USA
Attorney Name: Brian E. Farnan
Farnan LLP
Fresenius Kabi USA
Attorney Name: Arun J. Mohan
ArentFox Schiff
Fresenius Kabi USA
Attorney Name: Brian E. Farnan
Fresenius Kabi USA
Attorney Name: Arun J. Mohan
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09597397 | Formulations of bendamustine | Mar 21, 2017 |
| 09597398 | Formulations of bendamustine | Mar 21, 2017 |
| 09597399 | Formulations of bendamustine | Mar 21, 2017 |
| 09579384 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Feb 28, 2017 |
| 09572796 | Formulations of bendamustine | Feb 21, 2017 |
| 09572797 | Formulations of bendamustine | Feb 21, 2017 |
| 09572887 | Formulations of bendamustine | Feb 21, 2017 |
| 09265831 | Formulations of bendamustine | Feb 23, 2016 |
| 09144568 | Formulations of bendamustine | Sep 29, 2015 |
| 09034908 | Formulations of bendamustine | May 19, 2015 |
| 09000021 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Apr 7, 2015 |
| 08791270 | Bendamustine pharmaceutical compositions | Jul 29, 2014 |
| 08609707 | Formulations of bendamustine | Dec 17, 2013 |
